Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HNC: Human Neural Circuits Electrophysiology During Cognition
NCT05962424Phase 1Recruiting
- Sponsor
- Stanford University
- Start
- Oct 2023
- Primary completion
- Sep 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in psychiatric disorder, sponsored by Stanford University. Primary endpoint: Number of participants with dissociative events at 1 week. Started Oct 2023; status: recruiting.
02
Drugs
ketamine
03
Conditions
psychiatric disorder
Beyond the preview
Go deeper on NCT05962424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05962424.